Insiders who reported open-market trades in the last 12 months at the companies George W. Lemaitre files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
David B. Roberts - $1.26M in LMAT purchases and sales in the last 12 months
Trent G. Kamke - $713K in LMAT purchases and sales in the last 12 months
Bridget A. Ross - $560K in LMAT purchases and sales in the last 12 months
George W. Lemaitre is a corporate insider, tracked as Chairman and CEO, Director of LEMAITRE VASCULAR INC (LMAT). InsiderAlpha holds 22 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has George W. Lemaitre submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has George W. Lemaitre been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($44.98M) across all tracked filings.
George W. Lemaitre is Chairman and CEO, Director of LEMAITRE VASCULAR INC (LMAT). 22 SEC Form 4 filings on record going back to 2024, most recently on 8 September 2026. Most recent open-market trade: sold $3.03M of LMAT on 11 May 2026. Lifetime open-market sales: $44.98M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by George W. Lemaitre.
InsiderAlpha's records for George W. Lemaitre go back to 2024: 22 primary Form 4 filings, an average of 7.3 per year. 7 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
